Literature DB >> 24014302

Inherited susceptibility to CLL.

Helen E Speedy1, Georgina Sava, Richard S Houlston.   

Abstract

Chronic lymphocytic leukaemia (CLL) is the most common lymphoid malignancy in Western countries, accounting for around a quarter of all leukaemias. Despite a strong familial basis to CLL, with risks in first-degree relatives of CLL cases being increased around sevenfold, the inherited genetic basis of CLL is currently largely unknown. The failure of genetic studies of CLL families to provide support for a major disease-causing locus has suggested a model of susceptibility based on the co-inheritance of multiple low-risk variants, some of which will be common. Recent genome-wide association studies of CLL have vindicated this model of inherited susceptibility to CLL, identifying common variants at multiple independent loci influencing risk. Here we review the evidence for inherited genetic predisposition to CLL and what the currently identified risk loci are telling us about the biology of CLL development.

Entities:  

Mesh:

Year:  2013        PMID: 24014302     DOI: 10.1007/978-1-4614-8051-8_13

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  6 in total

Review 1.  The molecular pathogenesis of chronic lymphocytic leukaemia.

Authors:  Giulia Fabbri; Riccardo Dalla-Favera
Journal:  Nat Rev Cancer       Date:  2016-03       Impact factor: 60.716

Review 2.  Familial leukemias.

Authors:  Peter H Wiernik
Journal:  Curr Treat Options Oncol       Date:  2015-02

3.  Inherited polymorphisms in hyaluronan synthase 1 predict risk of systemic B-cell malignancies but not of breast cancer.

Authors:  Hemalatha Kuppusamy; Helga M Ogmundsdottir; Eva Baigorri; Amanda Warkentin; Hlif Steingrimsdottir; Vilhelmina Haraldsdottir; Michael J Mant; John Mackey; James B Johnston; Sophia Adamia; Andrew R Belch; Linda M Pilarski
Journal:  PLoS One       Date:  2014-06-20       Impact factor: 3.240

4.  Inheritance of Susceptibility to Malignant Blood Disorders.

Authors:  Viggo Jønsson; Haneef Awan; Neil D Jones; Tom B Johannesen; Bjarni Á Steig; Gudrid Andosdottir; Geir E Tjønnfjord
Journal:  Sci Rep       Date:  2019-02-21       Impact factor: 4.379

5.  Evaluation of a Prognostic Epigenetic Classification System in Chronic Lymphocytic Leukemia Patients.

Authors:  Christina Grimm; Carmen Diana Herling; Anastasia Komnidi; Michelle Hussong; Karl-Anton Kreuzer; Michael Hallek; Michal R Schweiger
Journal:  Biomark Insights       Date:  2022-01-19

Review 6.  Pathogenesis of chronic lymphocytic leukemia and the development of novel therapeutic strategies.

Authors:  Yoshikane Kikushige
Journal:  J Clin Exp Hematop       Date:  2020-11-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.